Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1971 2
1972 2
1973 3
1974 1
1975 4
1976 2
1977 2
1978 2
1979 2
1981 2
1982 4
1983 3
1984 4
1985 1
1986 7
1987 8
1988 7
1989 17
1990 16
1991 9
1992 12
1993 7
1994 8
1995 9
1996 16
1997 12
1998 12
1999 7
2000 19
2001 10
2002 15
2003 19
2004 17
2005 26
2006 29
2007 35
2008 28
2009 27
2010 21
2011 34
2012 26
2013 29
2014 34
2015 54
2016 44
2017 45
2018 28
2019 32
2020 25
2021 27
2022 51
2023 41
2024 31

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

839 results

Results by year

Filters applied: . Clear all
Page 1
Dual Immune Checkpoint Inhibition in Patients With Aggressive Thyroid Carcinoma: A Phase 2 Nonrandomized Clinical Trial.
Sehgal K, Pappa T, Shin KY, Schiantarelli J, Liu M, Ricker C, Besson NR, Jones SM, Welsh EL, Pfaff KL, Barletta JA, Park J, Reardon B, Doherty GM, Alexander EK, Rodig SJ, Barbie DA, O'Neill A, Van Allen E, Haddad RI, Lorch JH. Sehgal K, et al. Among authors: jones sm. JAMA Oncol. 2024 Oct 24:e244019. doi: 10.1001/jamaoncol.2024.4019. Online ahead of print. JAMA Oncol. 2024. PMID: 39446365
Low PD-L1 expression, MAP2K2 alterations, and enriched HPV gene signatures characterize brain metastases in head and neck squamous cell carcinoma.
Dennis MJ, Pavlick DC, Kacew A, Wotman M, MacConaill LE, Jones SM, Pfaff KL, Rodig SJ, Eacker S, Malig M, Reister E, Piccioni D, Kesari S, Sehgal K, Haddad RI, Cohen E, Posner MR, Deichaite I, Hanna GJ. Dennis MJ, et al. Among authors: jones sm. J Transl Med. 2024 Oct 22;22(1):960. doi: 10.1186/s12967-024-05761-z. J Transl Med. 2024. PMID: 39438862 Free PMC article.
Craters on the melanoma surface facilitate tumor-immune interactions and demonstrate pathologic response to checkpoint blockade in humans.
Ludin A, Stirtz GL, Tal A, Nirmal AJ, Besson N, Jones SM, Pfaff KL, Manos M, Liu S, Barrera I, Gong Q, Rodrigues CP, Sahu A, Jerison E, Alessi JV, Ricciuti B, Richardson DS, Weiss JD, Moreau HM, Stanhope ME, Afeyan AB, Sefton J, McCall WD, Formato E, Yang S, Zhou Y, van Konijnenburg DPH, Cole HL, Cordova M, Deng L, Rajadhyaksha M, Quake SR, Awad MM, Chen F, Sorger PK, Hodi FS, Rodig SJ, Murphy GF, Zon LI. Ludin A, et al. Among authors: jones sm. bioRxiv [Preprint]. 2024 Sep 19:2024.09.18.613595. doi: 10.1101/2024.09.18.613595. bioRxiv. 2024. PMID: 39345527 Free PMC article. Preprint.
Omalizumab Implementation in Practice: Lessons Learned From the OUtMATCH Study.
Vickery BP, Bird JA, Chinthrajah RS, Jones SM, Keet CA, Kim EH, Leung DYM, Shreffler WG, Sicherer SH, Sindher S, Spergel J, Wood RA. Vickery BP, et al. Among authors: jones sm. J Allergy Clin Immunol Pract. 2024 Nov;12(11):2947-2954. doi: 10.1016/j.jaip.2024.08.056. Epub 2024 Sep 16. J Allergy Clin Immunol Pract. 2024. PMID: 39293782
839 results